Abstract. The present report describes the birth of a healthy infant after cryopreservation of embryos produced from in vitro-matured oocytes retrieved from a woman at risk of developing ovarian hyperstimulation syndrome (OHSS) during conventional in vitro fertilization (IVF) cycles. A conventional long protocol including gonadotropin-releasing hormone agonist (GnRHa) and gonadotropins induced a risk of OHSS. Oocyte retrieval was performed on day 11 of the cycle, and 27 immature oocytes were obtained. Following incubation for 24 h in maturation medium, 74.1% (20/27) of the oocytes were at the metaphase II stage. Fourteen oocytes (14/20, 70.0%) were fertilized after intracytoplasmic sperm injection (ICSI) with her husband's spermatozoa and cultured for 3 days. On day 4 following oocyte retrieval, three embryos at the 8-16 cell stage were transferred into the woman's uterus, and five spare embryos were frozen. Since the fresh embryo transfer failed to result in pregnancy, three post-thaw embryos were transferred into the woman three months later. Transfer of the frozen embryos resulted in pregnancy with delivery of a healthy infant girl. Key words: Cryopreservation, Human, Intracytoplasmic sperm injection (ICSI), In vitro maturation (IVM), Ovarian hyperstimulation syndrome (OHSS) (J. Reprod. Dev. 53: [449][450][451][452][453] 2007) varian hyperstimulation syndrome (OHSS) is a serious iatrogenic complication due to vigorous r e s p o n s e t o o v a r i a n s t i m u l a t i o n d u r i n g conventional in vitro fertilization (IVF) cycles that could be life-threatening. Risk factors predisposing to OHSS include polycystic ovarian disease (PCOD), young age, history of previous OHSS and low body weight. Child [1] and Chian [2] have demonstrated that immature oocytes retrieved from minimally stimulated or nonstimulated normal ovaries, polycystic ovaries and women with polycystic ovary syndrome (PCOS) followed by in v i t r o m a t u r a t i o n ( I V M ) h a v e r e a s o n a b l e maturation, fertilization and development potential and that reasonable pregnancy rates can be achieved. Therefore, IVM treatment may be a solution for avoidance of the occurrence of OHSS in women with the risk factors above, especially in women with PCOS and a history of previous OHSS. However, it has been reported that the incidence of OHSS is as high as 33%, with severe OHSS occurring in 0.5-4% of patients with ovarian stimulation [3]. The following indicators can be